A blood based entire body screen to find HPV induced cancer early - all within minutes and by using just one drop of blood
Rapid test for detecting HPV16 induced carcinomas early. Easy to use in doctor's practice.
Clinical specificity > 99%
Learn more about screening for HPV induced cancer in the white paper series "Guidelines for identifying high-risk patients"
Interactive training resources on early detection of HPV-induced carcinomas
Moving from cell to blood based HPV cancer screening.
Abviris offers a new patented generation of Immune Oncology Diagnostics for early detection of HPV induced cancer, allowing a blood based entire body screen within minutes just using one drop of blood.
News
Abviris attracts almost 2M Euros to boost HPV cancer biomarker expansion
NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: jennie@carverwilde.com FOR IMMEDIATE RELEASE Abviris attracts almost 2M Euros to boost HPV cancer biomarker expansion Clinical study shows efficacy of novel lateral flow test AHRENSBURG, Germany (March 16, 2021) – Existing investors in …
Biotech innovator Abviris appoints new leader to drive business expansion
NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: jennie@carverwilde.com FOR IMMEDIATE RELEASE Biotech innovator Abviris appoints new leader to drive business expansion Diagnostics industry expert Dr Roman Niedbal joins as CEO AHRENSBURG, Germany (December 16, 2020) –Abviris Deutschland GmbH has appointed …
‘Pinprick’ biomarker blood test offers diagnostic potential in HPV-related cancers
NEWS RELEASE Media Contact: Jennie Wilde, Carver Wilde Communications t: +44 (0) 7799 412230/ +44 (0)203 814 8445 e: jennie@carverwilde.com FOR IMMEDIATE RELEASE ‘Pinprick’ biomarker blood test offers diagnostic potential in HPV-related cancers Study shows rising antibody levels predict the course of cancer AHRENSBURG, Germany (November 10, 2020) – A potential breakthrough in …
